NOVA Trademark

Trademark Overview

On Monday, February 13, 2023, a trademark application was filed for NOVA with the United States Patent and Trademark Office. The USPTO has given the NOVA trademark a serial number of 97792711. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, July 18, 2025. This trademark is owned by Helix Biotech, Inc. The NOVA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples, Formulation, Manufacturing, and Analytical Services; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles
nova

General Information

Serial Number97792711
Word MarkNOVA
Filing DateMonday, February 13, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, July 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements

Goods and ServicesProduct development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples, Formulation, Manufacturing, and Analytical Services; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 2, 2023
Primary Code042
First Use Anywhere DateTuesday, May 20, 2025
First Use In Commerce DateTuesday, May 20, 2025

Trademark Owner History

Party NameHelix Biotech, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKnoxville, TN 37918
Party NameHelix Biotech, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKnoxville, TN 37918

Trademark Events

Event DateEvent Description
Wednesday, November 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 16, 2023NEW APPLICATION ENTERED
Thursday, March 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 10, 2023ASSIGNED TO EXAMINER
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Thursday, January 4, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, January 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 7, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, March 11, 2024ASSIGNED TO PETITION STAFF
Sunday, April 28, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, January 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 20, 2024POST PUBLICATION AMENDMENT - ENTERED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 4, 2024SOU EXTENSION 1 FILED
Wednesday, December 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 16, 2025SOU EXTENSION 1 GRANTED
Friday, January 17, 2025USE AMENDMENT FILED
Friday, January 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 17, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, March 27, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 3, 2025SU - NON-FINAL ACTION - WRITTEN
Thursday, April 3, 2025NON-FINAL ACTION E-MAILED
Monday, June 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 2, 2025ASSIGNED TO LIE
Monday, June 2, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 18, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

nova nanoparticles lipid field consulting services planning design implementation liposomes hybrid